Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47370)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (5878)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226516)
Epigenetic Epidemiology Publications Database (22780)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Rare Diseases
Last data update: Apr 25, 2024
. (Total: 63675 Documents since 2012)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 63 Records)
Next
Query Trace:
Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma
SM Setayesh et al, NPJ Prec Oncol September 18, 2023
MGP Panel is a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients.
Sudha Parvathi et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022
Similar articles in PubMed
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma; A population-based study.
Langseth Øystein O et al. European journal of haematology 2022
Similar articles in PubMed
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.
Alaterre Elina et al. Theranostics 2022 12(4) 1715-1729
Similar articles in PubMed
Impact of Omicron variant on the response to SARS-CoV-2 mRNA vaccination in multiple myeloma and monoclonal gammopathies
P Storti et al, MEDRXIV, February 26, 2022
A polygenic risk score for multiple myeloma risk prediction.
Canzian Federico et al. European journal of human genetics : EJHG 2021
Similar articles in PubMed
High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.
Coffey David G et al. JCO precision oncology 2021 5
Similar articles in PubMed
Single-cell RNA sequencing: one step closer to the clinic- Single-cell RNA-sequencing can help in the prediction of drug resistance in patients with multiple myeloma
RS Pistofidis et al, Nature Medicine, March 4, 2021
Q&A: John Carpten on the Genomics of Cancer Disparities.
et al. Cancer discovery 2020 Sep
Similar articles in PubMed
Delineating the Complex Genomic Landscape of Multiple Myeloma Using Next-Generation Sequencing (NGS): Progress and Potential to Supersede Traditional Genetic Testing.
Garcia-Heras Jaime et al. Journal of the Association of Genetic Technologists 2020 46(3) 131-134
Similar articles in PubMed
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.
Martinez-Lopez Joaquin et al. Blood advances 2020 Jul 4(14) 3295-3301
Similar articles in PubMed
Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies.
Mehravar Maryam et al. Immunology letters 2020 Jul
Similar articles in PubMed
Clinical utility of target capture-based panel sequencing in hematological malignancies: a multicenter feasibility study.
Yasuda Takahiko et al. Cancer science 2020 Jul
Similar articles in PubMed
Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar Abhishek A et al. Mayo Clinic proceedings 2020 Jun
Similar articles in PubMed
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
Bolli Niccolo et al. Frontiers in oncology 2020 10189
Similar articles in PubMed
Upgraded standardized minimal residual disease detection by next-generation sequencing in multiple myeloma.
Yao Qiumei et al. The Journal of molecular diagnostics : JMD 2020 Mar
Similar articles in PubMed
Multiple Myeloma Genomics - A Concise Review.
Castaneda Omar et al. Acta medica academica 2019 Apr 48(1) 57-67
Similar articles in PubMed
Prognostic model for multiple myeloma progression integrating gene expression and clinical features.
Sun Chen et al. GigaScience 2019 Dec 8(12)
Similar articles in PubMed
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
Yellapantula Venkata et al. Blood cancer journal 2019 Dec 9(12) 101
Similar articles in PubMed
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review.
Maura Francesco et al. JAMA oncology 2019 Dec
Similar articles in PubMed
Doctors try CRISPR gene editing for cancer, a 1st in the US
M Marchione, Washington Post, November 6, 2019
CRISPR Approach To Fighting Cancer Called 'Promising' In 1st Safety Test
R Stein, NPR, November 6, 2019
Crispr Takes Its First Steps in Editing Genes to Fight Cancer
D Grady, NY Times, November 6, 2019
Toward personalized treatment in multiple myeloma based on molecular characteristics.
Pawlyn Charlotte et al. Blood 2019 133(7) 660-675
Similar articles in PubMed
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.
Caers Jo et al. Haematologica 2018 Nov 103(11) 1772-1784
Similar articles in PubMed
Family Members at Higher Risk for Blood Cancers
P Harrison, Medscape, September 9, 2019
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis.
Manasanch Elisabet E et al. Blood advances 2019 Aug 3(15) 2400-2408
Similar articles in PubMed
CRISPR enters its first human clinical trials- The gene editor targets cancer, blood disorders and blindness
T Hesman, Science News, August 14, 2019
FDA Approvals Provide Advances for a Range of Cancer Types
K Honey, AACR Blogs, August 6, 2019
Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an Example.
Blocka Joanna et al. Clinical lymphoma, myeloma & leukemia 2019 Jul
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 25, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP